Regulus Therapeutics
RGLS
#8339
Rank
S$0.15 B
Marketcap
$2.37
Share price
6.43%
Change (1 day)
34.63%
Change (1 year)

Regulus Therapeutics (RGLS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$7.73 M

According to Regulus Therapeutics's latest financial reports the company's total liabilities are S$7.73 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regulus Therapeutics - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31S$17.99 M-1.12%
2021-12-31S$18.2 M18.91%
2020-12-31S$15.3 M-48.41%
2019-12-31S$29.67 M-35.52%
2018-12-31S$46.01 M-19.22%
2017-12-31S$56.96 M-11.72%
2016-12-31S$64.52 M168.03%
2015-12-31S$24.07 M-53.83%
2014-12-31S$52.14 M38.98%
2013-12-31S$37.51 M-25.99%
2012-12-31S$50.69 M-53.61%
2011-12-31S$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$73.00 B 943,744.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$79.25 B 1,024,549.71%๐Ÿ‡ซ๐Ÿ‡ท France
S$14.21 B 183,716.10%๐Ÿ‡บ๐Ÿ‡ธ USA
S$84.32 B 1,090,199.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$5.22 B 67,476.63%๐Ÿ‡บ๐Ÿ‡ธ USA
S$90.29 M 1,067.46%๐Ÿ‡บ๐Ÿ‡ธ USA
S$101.04 B 1,306,349.98%๐Ÿ‡บ๐Ÿ‡ธ USA